Dr. Skinner gives advice to medical students pursuing urology
“One of the hardest things and one of the most important things is to figure out what part of urology excites you the most and look for those opportunities,” says Eila C. Skinner, MD.
In this video, Eila C. Skinner, MD, discusses why medical students should pursue the field of urology and why women especially should not be discouraged or intimidated by this subspecialty. Skinner is a urologic oncologist and Thomas A. Stamey research professor of urology at Stanford Health in Stanford, California. She is also the recipient of the Society of Urologic Oncology’s 2020 Huggins Medal, and the first woman in history to receive the award.
Lenvatinib/pembrolizumab compares favorably with frontline standards in renal cell carcinoma
February 2nd 2024“Combination therapy with lenvatinib plus pembrolizumab provides a comparable OS, and a trend of improvement in PFS and response outcomes, compared with most current global SOC therapies for treatment-naïve patients with advanced renal cell carcinoma,” the study authors wrote.
First-line pembrolizumab/lenvatinib shows efficacy for advanced non–clear cell RCC
January 29th 2024“Updated efficacy and safety results continue to support pembrolizumab plus lenvatinib as a first-line treatment option for patients with advanced non–clear cell RCC,” lead study author Martin H. Voss, MD.
